Suppr超能文献

前交叉韧带重建中双束和单束技术具有相似的成本-效用。

Similar cost-utility for double- and single-bundle techniques in ACL reconstruction.

机构信息

Department of Research and Development, NU Hospital Group, Trollhättan, Sweden.

Institute of Clinical Sciences, Gothenburg University, Gothenburg, Sweden.

出版信息

Knee Surg Sports Traumatol Arthrosc. 2018 Feb;26(2):634-647. doi: 10.1007/s00167-017-4725-1. Epub 2017 Sep 22.

Abstract

PURPOSE

The aim was to estimate the cost-utility of the DB technique (n = 53) compared with the SB (n = 50) technique 2 years after ACL reconstruction.

METHODS

One hundred and five patients with an ACL injury were randomised to either the Double-bundle (DB) or the Single-bundle (SB) technique. One hundred and three patients (SBG n = 50, DBG n = 53) attended the 2-year follow-up examination. The mean age was 27.5 (8.4) years in the SBG and 30.1 (9.1) years in the DBG. The cost per quality-adjusted life years (QALYs) was used as the primary outcome. Direct costs were the cost of health care, in this case outpatient procedures. Indirect costs are costs related to reduce work ability for health reasons. The cost-utility analysis was measured in terms of QALY gained.

RESULTS

The groups were comparable in terms of clinical outcome. Operating room time was statistically significantly longer in the DBG (p = 0.001), making the direct costs statistically significantly higher in the DBG (p = 0.005). There was no significant difference in QALYs between groups. In the cost-effectiveness plane, the mean difference in costs and QALYs from the trial data using 1000 bootstrap replicates in order to visualise the uncertainty associated with the mean incremental cost-effectiveness ratio (ICER) estimate showed that the ICERs were spread out over all quadrants. The cost-effectiveness acceptability curve showed that there was a 50% probability of the DB being cost-effective at a threshold of Euro 50,000.

CONCLUSION

The principal findings are that the DB is more expensive from a health-care perspective. This suggests that the physician may choose individualised treatment to match the patients' expectations and requirements.

摘要

目的

本研究旨在比较 ACL 重建后 2 年时 DB 技术(n=53)与 SB 技术(n=50)的成本效用。

方法

105 例 ACL 损伤患者被随机分为双束(DB)或单束(SB)技术组。103 例患者(SBG n=50,DBG n=53)接受了 2 年随访检查。SBG 的平均年龄为 27.5(8.4)岁,DBG 为 30.1(9.1)岁。质量调整生命年(QALY)的成本作为主要结局。直接成本是医疗保健的成本,在这种情况下是门诊程序的成本。间接成本是与因健康原因减少工作能力相关的成本。成本效用分析以获得的 QALY 衡量。

结果

两组在临床结果方面具有可比性。DBG 的手术室时间在统计学上显著更长(p=0.001),使得 DBG 的直接成本在统计学上显著更高(p=0.005)。两组之间 QALY 无显著差异。在成本效果平面上,使用 1000 次 bootstrap 重复的试验数据计算平均差异的成本和 QALY,以直观地显示与平均增量成本效果比(ICER)估计相关的不确定性,结果表明 ICER 分布在所有象限中。成本效果接受性曲线表明,在阈值为 50000 欧元时,DB 具有 50%的可能性具有成本效益。

结论

主要发现是从医疗保健角度来看,DB 更昂贵。这表明医生可以选择个体化治疗以满足患者的期望和需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae7/5794842/9cb5fd8b01b5/167_2017_4725_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验